Type
. [Guideline for the treatment of Hansen's disease in Japan (Second edition)]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2006;75(3):191-226.
Type
. Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome. Journal of clinical microbiology [Internet]. 2006;44(12):4616-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698401/pdf/1425-06.pdf
Type
. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae. Nepal Medical College journal : NMCJ. 2006;8(2):122-7.
Type
. Mycobacterium leprae is naturally resistant to PA-824. Antimicrobial agents and chemotherapy [Internet]. 2006;50(10):3350-4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1610092/pdf/0488-06.pdf
Type
. Detection of antibodies against Mycobacterium leprae culture filtrate protein-10 in leprosy patients. Journal of medical microbiology. 2006;55(Pt 10):1337-41.
Type
. Effect of thalidomide on the expression of TNF-alpha m-RNA and synthesis of TNF-alpha in cells from leprosy patients with reversal reaction. Immunopharmacology and immunotoxicology. 2006;28(3):431-41.
Type
. Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae. Seminars in immunology. 2006;18(6):404-10.
Type
. Leprosy. Clinical evidence. 2006;(15):1079-87.
Type
. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients. Scandinavian journal of immunology. 2006;64(4):450-5.
Type
. Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles. Infection and immunity. 2006;74(11):6458-66.